Achyut Healthcare Ltd

Achyut Healthcare Limited was incorporated as Achyut Securities Private Limited' on January 11, 1996 as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The Company name was changed to Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002. Subsequently, the Company got converted from a Private Limited to Public Limited and the name of the Company changed to Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021 was issued to the Company by Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products. The Company is currently trading pharmaceutical products based on the customers' requirements and customization both to domestic and international borders with each product being traded having its own strengths and significant key areas. With the help of its long-standing market presence and the superior quality of products, the Company has been able to create a pan-India India and International market presence in trading of pharmaceuticals business with the products being traded in different countries namely UAE, Kenya and Nigeria along with all over India catering to various end users, merchants, distributors and exporters. The Company has a dedicated team of professionals for managing and overseeing the procurement, marketing, selling and delivering of the products. The multi-location facilities of the Company has aided in market penetration and developing a strong presence in India and abroad. In 2015, the Company ventured into the business of trading of pharmaceutical products providing customized tailor made solutions to its clients and customers. The Company made a public issue of 18,00,000 Equity Shares through IPO by raising funds aggregating to Rs. 3.6 Crore in March, 2022.